- Home
- -
Bioscience
![](https://kemri-wellcome.org/zp-content/uploads/avatars/40/1659322402-bpfull.jpg)
Dr Eunice Nduati 9
Principal Investigator
Biography
Upon completion of her PhD training, Euniece was awarded a Wellcome Training Fellowship to determine whether exposure to HIV antigens or to an altered cytokine environment in utero alters the developing immune responses in HIV-exposed but uninfected infants. In parallel determined immune responses to childhood vaccines in HIV infected children. In 2017, she was awarded a four-years mid-career research fellowship through the Initiative to develop African Research Leaders (IDEAL) - DELTAS programme. This fellowship supported my work to understand cellular and molecular mechanisms involved in the generation of antibodies with relevant functions in HIV infection. During this time, I established collaboration with the International AIDS vaccine Initiative (IAVI) which is currently supporting my programme of work to characterize B cell responses and monoclonal antibodies to inform HIV vaccine design
Current Work
Collaborations
Project Research
No active details yet
Videos
Publications
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Hamaluba, M., Sang, S., Orindi, B., Njau, I., Karanja, H., Kamau, N., Gitonga, J. N., Mugo, D., Wright, D., Nyagwange, J., Kutima, B., Omuoyo, D., Mwatasa, M., Ngetsa, C., Agoti, C., Cheruiyot, S., Nyaguara, A., Munene, M., Mturi, N., Oloo, E., Ochola-Oyier, L., Mumba, N., Mauncho, C., Namayi, R., Davies, A., Tsofa, B., Nduati, E. W., Aliyan, N., Kasera, K., Etyang, A., Boyd, A., Hill, A., Gilbert, S., Douglas, A., Pollard, A., Bejon, P., Lambe, T., Warimwe, G.
Wellcome Open Res, (2023). 8:182
Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.
Fwambah, L., Andisi, C., Streatfield, C., Bromell, R., Hare, J., Esbjornsson, J., Ndung'u, T., Sanders, E. J., Hassan, A. S., Nduati, E.
Front Immunol, (2023). 14:1283559
Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.
Nyagwange, J., Kutima, B., Mwai, K., Karanja, H. K., Gitonga, J. N., Mugo, D., Sein, Y., Wright, D., Omuoyo, D. O., Nyiro, J. U., Tuju, J., Nokes, D. J., Agweyu, A., Bejon, P., Ochola-Oyier, L. I., Scott, J. A. G., Lambe, T., Nduati, E., Agoti, C., Warimwe, G. M.
Int J Infect Dis, (2022). 127:11-16
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Fernandez, N., Hayes, P., Makinde, J., Hare, J., King, D., Xu, R., Rehawi, O., Mezzell, A. T., Kato, L., Mugaba, S., Serwanga, J., Chemweno, J., Nduati, E., Price, M. A., Osier, F., Ochsenbauer, C., Yue, L., Hunter, E., Gilmour, J.
Front Immunol, (2022). 13:1029029
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.
Makinde, J., Nduati, E. W., Freni-Sterrantino, A., Streatfield, C., Kibirige, C., Dalel, J., Black, S. L., Hayes, P., Macharia, G., Hare, J., McGowan, E., Abel, B., King, D., Joseph, S., Iavi Protocol C Investigators., Hunter, E., Sanders, E. J., Price, M., Gilmour, J.
Front Immunol, (2021). 12:634832